Global ETD Search

1	Inhibition of IGF-I and B-FGF Stimulated Growth of Human Retinal Endothelial Cells by the Somatostatin Analogue, Octreotide: A Potential Treatment for Ocular Neovascularization Grant, Maria B., Caballero, Sergio, Millard, William J. 20 October 1993 (has links) No description available. FGF Human IGF inhibition ocreotide ocular neovascularization somatostatin analogue
2	Akromegalie Plöckinger, Ursula 10 April 2001 (has links) Die Akromegalie - Folge eines Wachstumshormon (STH) sezernierenden Hypophysentumors - ist eine seltene Erkrankung. Bei früher Diagnose ist die Akromegalie gut behandelbar. Unbehandelt - oder zu spät behandelt - führt sie zu hoher Co-Morbidität und verkürzt das Leben. Endokrinologische Therapieziele wurden kürzlich definiert: Heilung bei STH / Acromegaly, caused by a growth hormone (GH)-secreting pituitary adenoma, is a rare disease. If diagnosed early therapeutic results are good. However, untreated or treated belatedly, acromegaly is associated with a high co-morbidity and reduced life-expectancy. The therapeutic goals have recently been defined as follows: complete remission or cure as GH Akromegalie transspenoidale Hypophysenadenomektomie Somatostatin-Analoga Dopamin-Agonist Acromegaly transsphenoidale pituitary surgery somatostatin analogue dopamin agonist 610 Medizin 33 Medizin YC 3800 ddc:610